Acamprosate calcium(Campral EC) is a GABA receptor agonist and modulator of glutamatergic systems; reduces alcohol consumption in animal models of alcohol addiction.
IC50 value:
Target: GABA receptor
Acamprosate, or N-acetyl homotaurine, is an N-methyl-D-aspartate receptor modulator approved by the Food and Drug Administration (FDA) as a pharmacological treatment for alcohol dependence.Acamprosate has low bioavailability, but also has an excellent tolerability and safety profile. In comparison with naltrexone and disulfiram, which are the other FDA-approved treatments for alcohol dependence, acamprosate is unique in that it is not metabolized by the liver and is also not impacted by alcohol use, so can be administered to patients with hepatitis or liver disease (a common comorbid condition among individuals with alcohol dependence) and to patients who continue drinking alcohol.
分子式
C10H20CaN2O8S2
分子量
200.24
CAS号
77337-73-6
中文名称
阿坎酸钙;乙酰高牛磺酸钙;3-(乙酰氨基)丙烷磺酸钙;坎普拉尔
运输条件
Room temperature in continental US; may vary elsewhere.